Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation

Experimental Cell Research

Volumn 286, Issue 2, 2003, Pages 355-365

  Takiguchi, Masufumi ^a,b   Achanzar, William E ^a   Qu, Wei ^a   Li, Guying ^a,c   Waalkes, Michael P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^c Neurogen Corporation   (United States)

Author keywords

Cadmium; Carcinogenesis; DNA methylation; DNA methyltransferase; Transformation

Indexed keywords

CADMIUM; DNA; DNA METHYLTRANSFERASE;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA BINDING; DNA METHYLATION; ENZYME ACTIVITY; EXPOSURE; INHIBITION KINETICS; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM;

EID: 0037960155     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00062-4     Document Type: Article

References (59)

1. International Agency for Research on Cancer. Beryllium, cadmium, mercury, and exposure in the glass manufacturing industry, in: International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vol. 58, IARC, Lyon, 1993.
2. National Toxicology Program. Ninth Report on Carcinogens. National Toxicology Program, Research Triangle Park, NC, 2000.
3. Waalkes M.P. Metal carcinogenesis. Sarker B. Heavy Metals in the Environment. 2002;Marcel Dekker, New York.
4. Waalkes M.P. Cadmium carcinogenesis in review. J. Inorg. Biochem. 79:2000;241-244.
5. Waalkes M.P., Poirer L.A. In vitro cadmium-DNA interactions cooperativity of cadmium binding and competitive antagonism by calcium, magnesium and zinc . Toxicol. Appl. Pharmacol. 75:1984;539-546.
6. Misra R.R., Smith G.T., Waalkes M.P. Evaluation of the direct genotoxic potential of cadmium in four different rodent cell lines. Toxicology. 126:1998;103-114.
7. Lohmann R.D., Beyersmann D. Cadmium and zinc mediated changes of the Ca(2+)-dependent endonuclease in apoptosis. Biochem. Biophys. Res. Commun. 190:1993;1097-1103.
8. Shimoda R., Nagamine T., Takagi H., Mori M., Waalkes M.P. Induction of apoptosis in cells by cadmium quantitative negative correlation between basal or induced metallothionein concentration and apoptotic rate . Toxicol. Sci. 64:2001;208-215.
9. Yuan C., Kadiiska M., Achanzar W.E., Mason R.P., Waalkes M.P. Possible role of caspase-3 inhibition in cadmium-induced blockage of apoptosis. Toxicol. Appl. Pharmacol. 164:2000;321-329.
10. Li E., Beard C., Jaenisch R. Role for DNA methylation in genomic imprinting. Nature. 366:1993;362-365.
11. Ferguson-Smith A.C., Sasaki H., Cattanach B.M., Surani M.A. Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature. 362:1993;751-755.
12. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 88:1997;471-481.
13. Goodman J.I., Watson R.E. Altered DNA methylation a secondary mechanism involved in carcinogenesis . Annu. Rev. Pharmacol. Toxicol. 42:2002;501-525.
14. Attwood J.T., Yung R.L., Richardson B.C. DNA methylation and the regulation of gene transcription. Cell. Mol. Life Sci. 59:2002;241-257.
15. Lauster R., Trautne T.A., Noyer-Weidner M. Cytosine-specific type II DNA methyltransferases. J. Mol. Biol. 206:1989;305-312.
16. Posfai J., Bhagwat A.S., Posfai G., Roberts R.J. Predictive motifs derived from cytosine methyltransferases. Nucleic Acids Res. 17:1989;2421-2435.
17. Finnegan E.J., Dennis E.S. Isolation and identification by sequence homology of a putative cytosine methyltransferase from Arabidopsis thaliana. Nucleic Acids Res. 21:1993;2383-2388.
18. Vertino P.M., Spillare E.A., Harris C.C., Baylin S.B. Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells. Cancer Res. 53:1993;1684-1689.
19. Makos M., Nelkin B.D., Chazin V.R., Cavenee W.K., Brodeur G.M., Baylin S.B. DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res. 53:1993;2715-2718.
20. Makos M., Nelkin B.D., Reite R.E., Gnarra J.R., Brooks J., Isaacs W., Linehan M., Baylin S.B. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res. 53:1993;2719-2722.
21. Wales M.M., Biel M.A., el Deiry W., Nelkin B.D., Issa J.P., Cavenee W.K., Kuerbitz S.J., Baylin S.B. p53 activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3. Nat. Med. 6:1995;570-577.
22. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. USA. 94:1997;10907-10912.
23. Lee Y.W., Broday L., Costa M. Effects of nickel on DNA methyltransferase activity and genomic DNA methylation levels. Mutat. Res. 415:1998;213-218.
24. Goering P.L., Waalkes M.P., Klaassen C.D. Toxicology of cadmium. Goyer R.A., Cherian M.G. Toxicology of Metals Biochemical Aspects . 1995;Springer-Verlag, Berlin.
25. Idoine J.B., Elliott J.M., Wilson M.J., Weisburger E.K. Rat liver cells in culture effect of storage, long-term culture, and transformation on some enzyme levels . In Vitro. 12:1976;541-553.
26. Gehrke C.W., Kuo K.C. Ribonucleoside analysis by reversed-phase high performance liquid chromatography. Gehrke C.W., Kuo K.C. Chromatography and Modification of Nucleosides, Part A. Vol. 45A:1990;Elsevier, Amsterdam.
27. Nihei N., Ichikawa T., Kawana Y., Kuramochi H., Kugoh H., Oshimura M., Hayata I., Shimazaki J., Ito H. Mapping of metastasis suppressor gene(s) for rat prostate cancer on the short arm of human chromosome 8 by irradiated microcell-mediated chromosome transfer. Genes Chromosomes Cancer. 17:1996;260-268.
28. Compere S.J., Palmiter R.D. DNA methylation controls the inducibility of the mouse metallothionein-I gene lymphoid cells. Cell. 25:1981;233-240.
29. Bhave M.R., Wilson M.J., Waalkes M.P. Methylation status and organization of the metallothionein-I gene in livers and testes of strains of mice resistant and susceptible to cadmium. Toxicology. 50:1988;231-245.
30. Eaton D.L., Toal B.F. Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biological tissues. Toxicol. Appl. Pharmacol. 66:1982;134-142.
31. Waalkes M.P., Rehm S. Chronic toxic and carcinogenic effects of cadmium chloride in male DBA/2NCr and NFS/NCr mice strain-dependent association with tumors of the hematopoteic system, injection site, liver, and lung . Fundam. Appl. Toxicol. 23:1994;21-21.
32. Waalkes M.P., Anver M.R., Diwan B.A. Chronic toxic and carcinogenic effects of oral cadmium in the Noble (NBL/Cr) rat induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate, and testes . J. Toxicol. Environ. Health. 58:1999;199-214.
33. Waalkes M.P., Anver M.R., Diwan B.A. Carcinogenic effects of cadmium in the Noble (NBL/Cr) rat induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative lesions of the dorsolateral prostate . Toxicol. Sci. 52:1999;154-161.
34. Achanzar W.E., Diwan B.A., Liu J., Quader S., Webber M.M., Waalkes M.P. Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res. 61:2001;455-458.
35. Nakamura K., Yasunaga Y., Ko D., Xu L.L., Moul J.W., Peehl D.M., Srivastava S., Rhim J.S. Cadmium-induced neoplastic transformation of human prostate epithelial cells. Int. J. Oncol. 20:2002;543-547.
36. Terracio L., Nachtigal M. Oncogenicity of rat prostate cells transformed in vitro with cadmium chloride. Arch. Toxicol. 61:1988;450-456.
37. Chibber R., Ord M. Cadmium-induced multistep transformation of cultured Indian muntjac skin fibroblasts. Biol. Met. 3:1990;213-221.
38. Joseph P., Muchnok T.K., Klishis M.L., Roberts J.R., Antonini J.M., Whong W.Z., Ong T. Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes role of cellular calcium and reactive oxygen species . Toxicol. Sci. 61:2001;295-303.
39. Baylin S.B., Herman J.G. DNA hypermethylation in tumorigenesis epigenetics joins genetics . Trends Genet. 16:2000;168-174.
40. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3:2002;415-428.
41. Beyersmann D., Hechtenberg S. Cadmium, gene regulation, and cellular signalling in mammalian cells. Toxicol. Appl. Pharmacol. 144:1997;247-261.
42. Ballestar E., Esteller M. The impact of chromatin in human cancer linking DNA methylation to gene silencing . Carcinogenesis. 23:2002;1103-1109.
43. Baylin S.B., Esteller M., Rountree M.R., Bachman K.E., Schuebel K., Herman J.G. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10:2001;687-692.
44. Feinberg A.P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 301:1983;89-92.
45. Esteller M., Herman J.G. Cancer as an epigenetic disease DNA methylation and chromatin alterations in human tumours . J. Pathol. 196:2002;1-7.
46. Chuang L.S., Hg H.H., Chia J.N., Li B.F.L. Characterization of independent DNA and multiple Zn-binding domains at the N terminus of human DNA-(cytosine-5) methyltransferase modulating the property of a DNA-binding domain by contiguous Zn-binding motifs . J. Mol. Biol. 257:1996;935-948.
47. Bestor T.H., Verdine G.L. DNA methyltransferases. Curr. Opin. Cell Biol. 6:1996;380-389.
48. Tao L., Yang S., Xie M., Kramer P.M., Pereira M.A. Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Cancer Lett. 158:2000;185-193.
49. Takahashi M., Barrett J.C., Tsutsui T. Transformation by inorganic arsenic compounds of normal Syrian hamster embryo cells into a neoplastic state in which they become anchorage-independent and cause tumors in newborn hamsters. Int. J. Cancer. 99:2002;629-634.
50. Abshire M.K., Devor D.E., Diwan B.A., Shaughnessy J.D., Waalkes M.P. In vitro exposure to cadmium in rat L6 myoblasts can result in both enhancement and suppression of malignant progression in vivo. Carcinogenesis. 17:1996;1349-1356.
51. Sharrard R.M., Royds J.A., Rogers S., Shorthouse A.J. Patterns of methylation of the c-myc gene in human colorectal cancer progression. Br. J. Cancer. 65:1992;667-672.
52. Simile M.M., Pascale R., De Miglio M.R., Nufris A., Daino L., Seddaiu M.A., Gaspa L., Feo F. Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. Cancer Lett. 79:1994;9-16.
53. Chen H., Liu J., Zhao C.Q., Diwan B.A., Merrick B.A., Waalkes M.P. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol. Appl. Pharmacol. 175:2001;260-268.
54. Shivapurkar N., Wilson M.J., Poirer L.A. Hypomethylation of DNA in ethionine-fed rats. Carcinogenesis. 5:1984;989-992.
55. Waalkes M.P., Rehm S., Coogan T.P., Ward J.M. Role of cadmium in the etiology of cancer of the prostate. Thomas J.A., Colby H.D. Endocrine Toxicology. 2nd Ed. 1997;Taylor Francis, Washington, DC.
56. Li L.C., Chui R., Nakajima K., Oh B.R., Au H.C., Dahiya R. Frequent methylation of estrogen receptor in prostate cancer correlation with tumor progression . Cancer Res. 60:2000;702-706.
57. Belinsky S.A., Nikula K.J., Baylin S.B., Issa J.P. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA. 93:1996;4045-4050.
58. Xu G., Zhou G., Jin T., Zhou T., Hammarstrom S., Bergh A., Nordberg G. Apoptosis and p53 gene expression in male reproductive tissues of cadmium exposed rats. Biometals. 12:1999;131-139.
59. Fang M.Z., Mar W., Cho M.H. Cadmium affects genes involved in growth regulation during two-stage transformation of Balb/3T3 cells. Toxicology. 177:2002;253-265.